Viatris Inc.
Key Metrics
- Previous Close
- $20.28
- 52-Week Range
- $10.15 – $21.20
- Market Cap
- $22.79B
- P/E (TTM)
- —
- EPS (TTM)
- -0.53
- Dividend Yield
- 2.37%
Advanced Metrics
- Price/Book
- 1.67
- PEG Ratio
- 3.69
- Return on Equity
- -4.21%
- Return on Assets
- 2.91%
- Gross Margin
- 41.13%
- Operating Margin
- 11.49%
- Profit Margin
- -4.13%
- Current Ratio
- 1.55
- Debt/Equity
- 0.99
- Total Debt
- $13.58B
- Free Cash Flow
- $3.16B
- Revenue Growth
- -0.30%
- Earnings Growth
- —
- Enterprise Value
- $34.82B
Market Snapshot
About
Viatris is a global healthcare company formed through the merger of Mylan and Upjohn, a division of Pfizer. The company focuses on developing, manufacturing, and distributing generic and branded pharmaceutical products across a wide range of therapeutic categories. Viatris serves patients in more than 165 countries with a mission to expand access to quality medicines worldwide.